News

Do you remember where you were when you first heard that two planes had crashed into New York’s Twin Towers? Or where you had your first kiss?  Our brains are wired to retain information that relates to the context in which highly significant events occurred.  This mechanism also underlies drug addiction and is the reason why hanging out in an environment or with people associated with memories of drug use often leads to relapse. 

New Delivery for Antibiotics Arms Medicine in the Fight against Antibiotic Resistance and COVID-19

Researchers at the Hebrew University of Jerusalem have developed an injectable antibiotic with a new mode of action, which could have a significant impact on the morbidity rate for pandemics such as COVID-19, Yissum, the technology transfer company of the Hebrew University announced today.

It is a fact that has long baffled doctors: Cancer in the small intestine is quite rare, whereas colorectal cancer, a neighboring though much smaller organ, is one of the leading causes of cancer death for men and women.  What is it about the colon that seems to “attract” cancer?

Global Survey of 4,000 Coronavirus Patients Supports Link Between COVID-19 and Loss of Smell and Taste

The researchers’ updated analysis: “preparations must be carried out for tightening the current restrictions. Given the current rate of infection, another outbreak will be significantly worse than the first.” They are not warning of a separate wave, but rather a resurgence of the second wave. 

A joint Israeli-Italian nanosatellite has been launched into space – with a Hebrew University experiment on board!  

New Drug Targets Common Viruses and Could Treat Current and Future COVID-19 Variants, Influenza, Zika, West Nile, Hepatitis and Future Threats

ViroBlock, a startup company founded by Hebrew University of Jerusalem (HU) researchers, has developed a new drug platform for rapidly generating anti-viral drugs that target proteins common to all viruses.